Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Mimura M"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 27
Tytuł:
Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders.
Autorzy:
Momota Y; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Department of Functional Brain Imaging Research, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba-Shi, Chiba, 263-8555, Japan.
Bun S; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan. .
Hirano J; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan. .
Kamiya K; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Ueda R; Office of Radiation Technology, Keio University Hospital, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Iwabuchi Y; Department of Radiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Takahata K; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Department of Functional Brain Imaging Research, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba-Shi, Chiba, 263-8555, Japan.
Yamamoto Y; Department of Functional Brain Imaging Research, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba-Shi, Chiba, 263-8555, Japan.
Tezuka T; Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Kubota M; Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Seki M; Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Shikimoto R; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Mimura Y; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Kishimoto T; Psychiatry Department, Donald and Barbara Zucker School of Medicine, Hempstead, NY, 11549, USA.; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Mori JP Tower F7, 1-3-1 Azabudai, Minato-ku, Tokyo, 106-0041, Japan.
Tabuchi H; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Jinzaki M; Department of Radiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Ito D; Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Memory Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Mimura M; Center for Preventive Medicine, Keio University, Mori JP Tower 7th Floor, 1-3-1 Azabudai, Minato-ku, Tokyo, 106-0041, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 01; Vol. 14 (1), pp. 7633. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/pathology
Cognitive Dysfunction*/diagnostic imaging
Cognitive Dysfunction*/pathology
Humans ; Brain/pathology ; Amyloid beta-Peptides ; Magnetic Resonance Imaging/methods ; Machine Learning ; Apolipoproteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Serum high-sensitivity C-reactive protein and dementia in a community-dwelling Japanese older population (JPSC-AD).
Autorzy:
Tachibana A; Department of Neuropsychiatry, Neuroscience, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Ehime, 791-0295, Japan.
Iga JI; Department of Neuropsychiatry, Neuroscience, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Ehime, 791-0295, Japan. .
Ozaki T; Department of Neuropsychiatry, Neuroscience, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Ehime, 791-0295, Japan.
Yoshida T; Department of Neuropsychiatry, Matsukaze Hospital, Shikokuchuo, Ehime, Japan.
Yoshino Y; Department of Neuropsychiatry, Neuroscience, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Ehime, 791-0295, Japan.
Shimizu H; Department of Psychiatry, Heisei Hospital, Ozu, Ehime, Japan.
Mori T; Department of Neuropsychiatry, Neuroscience, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Ehime, 791-0295, Japan.
Furuta Y; Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shibata M; Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ohara T; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hata J; Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Taki Y; Department of Aging Research and Geriatric Medicine, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Mikami T; Department of Preemptive Medicine, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan.
Maeda T; Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Iwate, Japan.
Ono K; Department of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Mimura M; Center for Preventive Medicine, Keio University School of Medicine, Tokyo, Japan.
Nakashima K; National Hospital Organization, Matsue Medical Center, Matsue, Shimane, Japan.
Takebayashi M; Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Ninomiya T; Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ueno SI; Department of Neuropsychiatry, Neuroscience, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Ehime, 791-0295, Japan.
Pokaż więcej
Corporate Authors:
JPSC-AD study group
Źródło:
Scientific reports [Sci Rep] 2024 Mar 28; Vol. 14 (1), pp. 7374. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
C-Reactive Protein*/metabolism
Alzheimer Disease*/epidemiology
Humans ; Japan/epidemiology ; Independent Living ; Risk Factors ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status.
Autorzy:
Bun S; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan. .
Ito D; Memory Center, Keio University School of Medicine, Tokyo, Japan.; Department of Physiology, Keio University School of Medicine, Tokyo, Japan.
Tezuka T; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Kubota M; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Ueda R; Office of Radiation Technology, Keio University Hospital, Tokyo, Japan.
Takahata K; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Moriguchi S; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Kurose S; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Momota Y; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Suzuki N; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Morimoto A; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Hoshino Y; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Seki M; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Mimura Y; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Shikimoto R; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Yamamoto Y; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Hoshino T; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Graduate School of Media and Governance, Keio University, Kanagawa, Japan.
Sato Y; Eisai-Keio Innovation Laboratory for Dementia, Human Biology Integration Foundation, Eisai Co., Ltd, Tokyo, Japan.
Tabuchi H; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Sep 04; Vol. 15 (1), pp. 149. Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Amyloid beta-Peptides*
Alzheimer Disease*/diagnostic imaging
Humans ; Amyloidogenic Proteins ; Immunoassay ; Positron-Emission Tomography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical characteristics and potential association to Parkinson's disease and dementia with Lewy bodies in patients with major depressive disorder who received maintenance electroconvulsive therapy: a retrospective chart review study.
Autorzy:
Kudo S; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Department of Psychiatry, Saitama City Hospital, Saitama, Japan.
Uchida T; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan. .; Department of Psychiatry, Melbourne Neuropsychiatry Centre, The University of Melbourne, Victoria, Australia. .
Nishida H; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Takamiya A; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Kikuchi T; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Yamagata B; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Hirano J; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2023 Apr 11; Vol. 23 (1), pp. 243. Date of Electronic Publication: 2023 Apr 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Parkinson Disease*
Depressive Disorder, Major*
Lewy Body Disease*
Electroconvulsive Therapy*/methods
Alzheimer Disease*
Humans ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Findings of F-PI-2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sample.
Autorzy:
Bun S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Moriguchi S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Tezuka T; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Sato Y; Eisai-Keio Innovation Laboratory for Dementia, hhcData Creation Center, Eisai Co., Ltd., Tokyo, Japan.
Takahata K; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Seki M; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Nakajima S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Yamamoto Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Sano Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
Suzuki N; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Morimoto A; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Ueda R; Office of Radiation Technology, Keio University Hospital, Tokyo, Japan.
Tabuchi H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Ito D; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2022 Dec; Vol. 42 (4), pp. 437-448. Date of Electronic Publication: 2022 Jul 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/metabolism
Humans ; Pilot Projects ; East Asian People ; Positron-Emission Tomography/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Caregiver self-efficacy and associated factors among caregivers of patients with dementia with Lewy bodies and caregivers of patients with Alzheimer's disease.
Autorzy:
Sato H; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Nakaaki S; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Sato J; Speech Language Hearing Therapy, School of Rehabilitation Science Seirei Christopher University, Shizuoka, Japan.
Shikimoto R; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Furukawa TA; Department of Health Promotion and Human Behavior (Cognitive-Behavioral Medicine), Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Akechi T; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2021 Sep; Vol. 21 (5), pp. 783-794. Date of Electronic Publication: 2021 Jul 03.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*
Lewy Body Disease*
Caregivers ; Humans ; Lewy Bodies ; Self Efficacy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effect of different parietal hypoperfusion on neuropsychological characteristics in mild cognitive impairment.
Autorzy:
Yamaguchi T; Department of Neuropsychiatry, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Tabuchi H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Ito D; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Saito N; Department of Rehabilitation, Keio University School of Medicine, Tokyo, Japan.
Yamagata B; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Konishi M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Takebayashi M; Department of Neuropsychiatry, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.; Department of Neuropsychiatry, Kumamoto University, Faculty of Medical and Pharmaceutical Sciences, Kumamoto, Japan.
Ikeda M; Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2021 Jul; Vol. 21 (4), pp. 618-626. Date of Electronic Publication: 2021 May 31.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*
Cognitive Dysfunction*
Aged ; Aged, 80 and over ; Brain ; Female ; Humans ; Memory Disorders ; Mental Recall ; Neuropsychological Tests ; Tomography, Emission-Computed, Single-Photon
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Group cognitive behavioural therapy for family caregivers of people with dementia: A single-arm pilot study.
Autorzy:
Shikimoto R; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Neuropsychiatry, Sakuragaoka Memorial Hospital, Tokyo, Japan.
Tamura N; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Neuropsychiatry, Sakuragaoka Memorial Hospital, Tokyo, Japan.
Irie S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Neuropsychiatry, Sakuragaoka Memorial Hospital, Tokyo, Japan.
Iwashita S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Neuropsychiatry, Sakuragaoka Memorial Hospital, Tokyo, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Neuropsychiatry, Sakuragaoka Memorial Hospital, Tokyo, Japan.
Fujisawa D; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Neuropsychiatry, Sakuragaoka Memorial Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2021 Jan; Vol. 21 (1), pp. 134-136. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*
Cognitive Behavioral Therapy*
Dementia*/therapy
Caregivers ; Family ; Humans ; Pilot Projects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of various items of the quality of life in Alzheimer's disease scale (QOL-AD) in patients with mild or moderate stages of dementia: a cross-sectional study.
Autorzy:
Shikimoto R; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Sakuragaoka Memorial Hospital, Tokyo, Japan.
Nakaaki S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Sato J; Speech Language Hearing Therapy, School of Rehabilitation Science Seirei Christopher University, Shizuoka, Japan.
Sato H; Sakuragaoka Memorial Hospital, Tokyo, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2020 Nov; Vol. 20 (6), pp. 926-928. Date of Electronic Publication: 2020 Aug 07.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/diagnosis
Dementia*/diagnosis
Cross-Sectional Studies ; Humans ; Quality of Life ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease.
Autorzy:
Kobayashi N; Department of Virology, The Jikei University School of Medicine, Tokyo, Japan. .; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan. .
Shinagawa S; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Niimura H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Kida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Nagata T; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Tagai K; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Shimada K; Department of Virology, The Jikei University School of Medicine, Tokyo, Japan.
Oka N; Department of Virology, The Jikei University School of Medicine, Tokyo, Japan.
Shikimoto R; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Noda Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Nakajima S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Shigeta M; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Kondo K; Department of Virology, The Jikei University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Jul 22; Vol. 10 (1), pp. 12217. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Alzheimer Disease/*diagnosis
Biomarkers/*blood
Transferases/*genetics
Aged ; Aged, 80 and over ; Alzheimer Disease/complications ; Alzheimer Disease/genetics ; Alzheimer Disease/pathology ; Apolipoproteins E/genetics ; Area Under Curve ; Base Sequence ; Cardiovascular Diseases/complications ; Case-Control Studies ; Cognitive Dysfunction/diagnosis ; Cognitive Dysfunction/genetics ; Cognitive Dysfunction/pathology ; Dementia, Vascular/complications ; Female ; Genotype ; Humans ; Male ; Promoter Regions, Genetic ; ROC Curve ; Severity of Illness Index ; Transferases/blood ; Transferases/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report.
Autorzy:
Mimura Y; Department of Neuropsychiatry, Japanese Red Cross Ashikaga Hospital, 49-1 Yobe, Ashikaga, Tochigi, Japan. yu.mimura@keio.jp.; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, Japan. yu.mimura@keio.jp.
Kurose S; Department of Neuropsychiatry, Japanese Red Cross Ashikaga Hospital, 49-1 Yobe, Ashikaga, Tochigi, Japan.; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, Japan.
Takata T; Department of Neuropsychiatry, Japanese Red Cross Ashikaga Hospital, 49-1 Yobe, Ashikaga, Tochigi, Japan.
Tabuchi H; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, Japan.
Funayama M; Department of Neuropsychiatry, Japanese Red Cross Ashikaga Hospital, 49-1 Yobe, Ashikaga, Tochigi, Japan.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2020 May 13; Vol. 20 (1), pp. 183. Date of Electronic Publication: 2020 May 13.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Alzheimer Disease/*drug therapy
Cholinesterase Inhibitors/*adverse effects
Galantamine/*adverse effects
Tardive Dyskinesia/*chemically induced
Donepezil/therapeutic use ; Female ; Humans ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model.
Autorzy:
Abe Y; Department of Pharmacology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. .; Center for Water Biology & Medicine, Keio University Global Research Institute, Mita, Tokyo, 108-8345, Japan. .
Ikegawa N; Department of Information and Communication Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo, 102-8554, Japan.
Yoshida K; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Sinjuku-ku, Tokyo, 160-8582, Japan.
Muramatsu K; Department of Neuropathology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Hattori S; Division of System Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Kawai K; Central Institute for Experimental Animals (CIEA), 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki, 210-0821, Japan.
Murakami M; Department of Information and Communication Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo, 102-8554, Japan.
Tanaka T; Department of Information and Communication Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo, 102-8554, Japan.
Goda W; Department of Pharmacology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Goto M; Central Institute for Experimental Animals (CIEA), 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki, 210-0821, Japan.
Yamamoto T; Central Institute for Experimental Animals (CIEA), 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki, 210-0821, Japan.
Hashimoto T; Department of Neuropathology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Yamada K; Department of Neuropathology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Shibata T; Department of Pharmacology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.; Division of Pharmacology, Faculty of Pharmacy, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.
Misawa H; Division of Pharmacology, Faculty of Pharmacy, Keio University, 1-5-30, Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Sinjuku-ku, Tokyo, 160-8582, Japan.
Tanaka KF; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Sinjuku-ku, Tokyo, 160-8582, Japan.
Miyakawa T; Division of System Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Iwatsubo T; Department of Neuropathology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Hata JI; Central Institute for Experimental Animals (CIEA), 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki, 210-0821, Japan.
Niikura T; Department of Information and Communication Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo, 102-8554, Japan.
Yasui M; Department of Pharmacology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. .; Center for Water Biology & Medicine, Keio University Global Research Institute, Mita, Tokyo, 108-8345, Japan. .
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2020 May 12; Vol. 8 (1), pp. 67. Date of Electronic Publication: 2020 May 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*metabolism
Aquaporin 4/*metabolism
Neuroprotection/*physiology
Alzheimer Disease/pathology ; Alzheimer Disease/physiopathology ; Animals ; Behavior, Animal ; Brain/metabolism ; Brain/pathology ; Brain/physiopathology ; Disease Models, Animal ; Female ; Humans ; Mice ; Mice, Knockout ; Mice, Transgenic ; Plaque, Amyloid/pathology ; Seizures/metabolism ; Seizures/physiopathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Factor structure of the Japanese version of the Quality of Life in Alzheimer's Disease Scale (QOL-AD).
Autorzy:
Yamada T; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Nakaaki S; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Sato J; Department of Speech-Language-Hearing Therapy, School of Rehabilitation Science Seirei Christopher University, Japan.
Sato H; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Shikimoto R; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Furukawa TA; Department of Health Promotion and Human Behavior (Cognitive-Behavioral Medicine), Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Akechi T; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2020 Jan; Vol. 20 (1), pp. 79-86. Date of Electronic Publication: 2019 Apr 24.
Typ publikacji:
Journal Article
MeSH Terms:
Factor Analysis, Statistical*
Neuropsychological Tests*
Alzheimer Disease/*psychology
Quality of Life/*psychology
Activities of Daily Living ; Aged ; Aged, 80 and over ; Caregivers/psychology ; Caregivers/statistics & numerical data ; Female ; Humans ; Interpersonal Relations ; Japan ; Male ; Middle Aged ; Patients/psychology ; Patients/statistics & numerical data ; Social Environment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detailed analysis of the Japanese version of the Rapid Dementia Screening Test using Arabic-hiragana conversion.
Autorzy:
Moriyama Y; Department of Psychiatry, Komagino Hospital, Tokyo, Japan.
Yoshino A; Department of Psychiatry, National Defense Medical College, Saitama, Japan.
Muramatsu T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2018 Nov; Vol. 18 (6), pp. 446-450. Date of Electronic Publication: 2018 Jul 30.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease/*diagnosis
Cognition Disorders/*diagnosis
Dementia/*diagnosis
Geriatric Assessment/*methods
Neuropsychological Tests/*standards
Aged ; Aged, 80 and over ; Case-Control Studies ; Cognition Disorders/ethnology ; Cognition Disorders/psychology ; Dementia/ethnology ; Dementia/psychology ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Geriatric Assessment/statistics & numerical data ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Neuropsychological Tests/statistics & numerical data ; Predictive Value of Tests ; Psychometrics ; Reproducibility of Results ; Sensitivity and Specificity ; Severity of Illness Index ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detailed analysis of the supermarket task included on the Japanese version of the Rapid Dementia Screening Test.
Autorzy:
Moriyama Y; Department of Psychiatry, Komagino Hospital, Tokyo, Japan.
Yoshino A; Department of Psychiatry, National Defense Medical College, Saitama, Japan.
Muramatsu T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2017 May; Vol. 17 (3), pp. 170-176. Date of Electronic Publication: 2016 Jun 30.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease/*diagnosis
Cognition Disorders/*diagnosis
Dementia/*diagnosis
Geriatric Assessment/*methods
Neuropsychological Tests/*standards
Aged ; Aged, 80 and over ; Alzheimer Disease/ethnology ; Alzheimer Disease/psychology ; Case-Control Studies ; Cluster Analysis ; Cognition Disorders/ethnology ; Cognition Disorders/psychology ; Dementia/ethnology ; Dementia/psychology ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Humans ; Japan ; Male ; Middle Aged ; Psychometrics ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detailed analysis of error patterns in the number-transcoding task on the Japanese version of the Rapid Dementia Screening Test.
Autorzy:
Moriyama Y; Department of Psychiatry, Komagino Hospital, Tokyo, Japan.
Yoshino A; Department of Psychiatry, National Defense Medical College, Saitama, Japan.
Muramatsu T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2017 May; Vol. 17 (3), pp. 164-169. Date of Electronic Publication: 2016 Jun 27.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease/*physiopathology
Brain/*physiopathology
Cognition/*physiology
Dementia/*physiopathology
Form Perception/*physiology
Neural Pathways/*physiology
Aged ; Aged, 80 and over ; Alzheimer Disease/diagnosis ; Dementia/diagnosis ; Female ; Humans ; Male ; Middle Aged ; Neuropsychological Tests ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Japanese version of the Rapid Dementia Screening Test is effective compared to the clock-drawing test for detecting patients with mild Alzheimer's disease.
Autorzy:
Moriyama Y; Psychiatry, Komagino Hospital, Tokyo, Japan.
Yoshino A; Psychiatry, National Defense Medical College, Saitama, Japan.
Yamanaka K; Psychiatry, Komagino Hospital, Tokyo, Japan.
Kato M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Muramatsu T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2016 Jul; Vol. 16 (4), pp. 233-9. Date of Electronic Publication: 2015 Jul 24.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease/*diagnosis
Cognition Disorders/*diagnosis
Dementia/*diagnosis
Neuropsychological Tests/*standards
Aged ; Aged, 80 and over ; Alzheimer Disease/ethnology ; Alzheimer Disease/psychology ; Case-Control Studies ; Cognition Disorders/ethnology ; Cognition Disorders/psychology ; Dementia/ethnology ; Dementia/psychology ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Geriatric Assessment/methods ; Humans ; Japan ; Male ; Psychometrics ; Reproducibility of Results ; Sensitivity and Specificity ; Severity of Illness Index ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
Autorzy:
Kudoh C; KUDOH Clinic for Neurosurgery and Neurology, Tokyo, Japan.; Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan.
Arita R; Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan.
Honda M; Department of General Medicine and Emergency Care, Toho University School of Medicine, Tokyo, Japan.
Kishi T; Department of Educational Planning and Development, Toho University School of Medicine, Tokyo, Japan.
Komatsu Y; Laboratory of Biochemical Pharmacology for Phytomedicine, Kirasato University, Kitasato Institute for Life Science, Tokyo, Japan.
Asou H; Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan.
Mimura M; Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2016 Mar; Vol. 16 (2), pp. 85-92. Date of Electronic Publication: 2015 Apr 27.
Typ publikacji:
Controlled Clinical Trial; Journal Article; Observational Study
MeSH Terms:
Panax*
Affect/*drug effects
Alzheimer Disease/*psychology
Cholinesterase Inhibitors/*therapeutic use
Cognition/*drug effects
Cognition Disorders/*drug therapy
Depression/*drug therapy
Drugs, Chinese Herbal/*pharmacology
Indans/*therapeutic use
Piperidines/*therapeutic use
Aged ; Aged, 80 and over ; Donepezil ; Female ; Humans ; Male ; Medicine, Kampo ; Prospective Studies ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease.
Autorzy:
Oka M; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Japan.
Nakaaki S; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Japan.
Negi A; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Japan.; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Miyata J; Department of Psychiatry, Graduate School of Medicine, Kyoto University, Sakyo-ku, Japan.
Nakagawa A; Center for Clinical Research, Keio University School of Medicine, Shinjuku-ku, Japan.
Hirono N; Department of Psychology, Kobegakuin University, Kobe, Japan.
Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2016 Mar; Vol. 16 (2), pp. 121-34. Date of Electronic Publication: 2015 Jun 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*diagnosis
Alzheimer Disease/*drug therapy
Apathy/*drug effects
Cholinesterase Inhibitors/*administration & dosage
Executive Function/*drug effects
Galantamine/*administration & dosage
Indans/*administration & dosage
Piperidines/*administration & dosage
Tomography, Emission-Computed, Single-Photon/*methods
Aged ; Aged, 80 and over ; Cholinesterase Inhibitors/therapeutic use ; Donepezil ; Female ; Galantamine/therapeutic use ; Humans ; Indans/therapeutic use ; Male ; Mental Status Schedule ; Middle Aged ; Neuropsychological Tests/statistics & numerical data ; Piperidines/therapeutic use ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reliability and validity of the Japanese version of the Agitated Behaviour in Dementia Scale in Alzheimer's disease: three dimensions of agitated behaviour in dementia.
Autorzy:
Torii K; Department of Psychiatry and Cognitive-Behavioural Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Nakaaki S
Banno K
Murata Y
Sato J
Tatsumi H
Yamanaka K
Narumoto J
Mimura M
Akechi T
Furukawa TA
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2011 Dec; Vol. 11 (4), pp. 212-20. Date of Electronic Publication: 2011 Oct 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:
Alzheimer Disease/*psychology
Psychomotor Agitation/*diagnosis
Psychomotor Agitation/*psychology
Aged ; Aggression/psychology ; Alzheimer Disease/epidemiology ; Caregivers ; Dementia ; Factor Analysis, Statistical ; Female ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Neuropsychological Tests ; Prevalence ; Psychiatric Status Rating Scales/statistics & numerical data ; Psychomotor Agitation/epidemiology ; Psychotic Disorders/diagnosis ; Psychotic Disorders/epidemiology ; Psychotic Disorders/psychology ; Reproducibility of Results ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 27

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies